These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17942451)
21. [Antibody therapy in hematology and oncology - part 1]. Kneba M; Schrader C; Köhne H Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214 [No Abstract] [Full Text] [Related]
23. [Monoclonal antibodies for lymphomas and leukemias in 2005]. Peffault de Latour R; Robin M; Bay JO Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies in the treatment of lymphoid leukemia. O'Brien S; Giles FJ Drugs Today (Barc); 2003 Jul; 39(7):541-50. PubMed ID: 12973402 [TBL] [Abstract][Full Text] [Related]
25. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia. De Decker M; Bacher K; Thierens H; Slegers G; Dierckx RA; De Vos F Nucl Med Biol; 2008 Jul; 35(5):599-604. PubMed ID: 18589304 [TBL] [Abstract][Full Text] [Related]
27. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Robak T Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872 [TBL] [Abstract][Full Text] [Related]
28. Current applications of monoclonal antibodies for the therapy of hematopoietic cancers. Scheinberg DA Curr Opin Immunol; 1991 Oct; 3(5):679-84. PubMed ID: 1661602 [TBL] [Abstract][Full Text] [Related]
29. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563 [TBL] [Abstract][Full Text] [Related]
30. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R; Hagenbeek A Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [TBL] [Abstract][Full Text] [Related]
33. Combination of chemotherapy and monoclonal antibodies for the treatment of lymphoma. Thieblemont C; Coiffier B Int J Hematol; 2002 Dec; 76(5):394-400. PubMed ID: 12512833 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody therapy of lymphomas and leukemia. Kaminski MS; Foon KA Cancer Treat Res; 1988; 38():253-63. PubMed ID: 2908598 [No Abstract] [Full Text] [Related]
35. Antibody therapy of lymphoma. Weiner GJ; Link BK Adv Pharmacol; 2004; 51():229-53. PubMed ID: 15464912 [No Abstract] [Full Text] [Related]
36. Monoclonal antibodies in the treatment of leukemia. O'Brien S; Albitar M; Giles FJ Curr Mol Med; 2005 Nov; 5(7):663-75. PubMed ID: 16305492 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody-based therapy of lymphoid neoplasms: what's on the horizon? Davis AT Semin Hematol; 2000 Oct; 37(4 Suppl 7):34-42. PubMed ID: 11147488 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies as therapeutic agents for cancer. Harris M Lancet Oncol; 2004 May; 5(5):292-302. PubMed ID: 15120666 [TBL] [Abstract][Full Text] [Related]
40. New monoclonal antibodies for hematologic malignancies (and breast cancer). Curtis MA Med Health R I; 2003 Aug; 86(8):256-7. PubMed ID: 14582224 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]